Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s and Non-Hodgkin’s Lymphoma with B-Cell or T-Cell Origin

This document is a response to public comments on the proposed Local Coverage Determination for allogeneic hematopoietic cell transplantation for primary refractory or relapsed Hodgkin's and non-Hodgkin's lymphoma (B- or T-cell). The text provided contains administrative timeline information (comment period, notice period, and LCD finalization date) but does not specify clinical coverage indications, limitations, documentation requirements for claims, or frequency limits.

"This document is a response to public comments on the proposed LCD for allogeneic hematopoietic cell transplantation for primary refractory or relapsed Hodgkin's and non-Hodgkin's lymphoma; comment..."

Sign up to see full coverage criteria, indications, and limitations.